ACHL logo

Achilles Therapeutics (ACHL) Company Overview

Profile

Full Name:

Achilles Therapeutics plc

Sector:

Healthcare

Industry:

Biotechnology

Country:

United Kingdom

IPO:

March 31, 2021

Indexes:

Not included

Description:

Achilles Therapeutics is a biotechnology company focused on developing personalized cancer therapies. They use advanced genetic techniques to identify and target unique tumor mutations, aiming to create effective treatments for patients with solid tumors, particularly in lung cancer. Their innovative approach seeks to improve patient outcomes in oncology.

Events Calendar

Earnings

Next earnings date:

Apr 4, 2025

Recent quarterly earnings:

Nov 14, 2024

Recent annual earnings:

Apr 4, 2024
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

Apr 5, 24 Piper Sandler
Neutral
Apr 5, 24 Chardan Capital
Buy
Dec 14, 23 B of A Securities
Underperform
Aug 7, 23 Chardan Capital
Buy
May 11, 23 Chardan Capital
Buy
Dec 7, 22 Piper Sandler
Overweight
Dec 7, 22 Chardan Capital
Buy
Apr 26, 21 Piper Sandler
Overweight
Apr 26, 21 Oppenheimer
Outperform
Apr 26, 21 JP Morgan
Underweight

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

Achilles Therapeutics Reports Third Quarter 2024 Financial Results
Achilles Therapeutics Reports Third Quarter 2024 Financial Results
Achilles Therapeutics Reports Third Quarter 2024 Financial Results
ACHL
globenewswire.comNovember 14, 2024

– Cash position of $86.1 million as of September 30, 2024, not including cash R&D tax credit of $12.8 million received in October 2024 –

Achilles Therapeutics to Present at Upcoming Conferences
Achilles Therapeutics to Present at Upcoming Conferences
Achilles Therapeutics to Present at Upcoming Conferences
ACHL
GlobeNewsWireJune 12, 2023

LONDON, June 12, 2023 (GLOBE NEWSWIRE) -- Achilles Therapeutics plc (NASDAQ: ACHL), a clinical-stage biopharmaceutical company developing AI-powered precision T cell therapies to treat solid tumors, today announced that the Company will be taking part in the following conferences in June:

3 Stocks With 1,000% Upside Potential
3 Stocks With 1,000% Upside Potential
3 Stocks With 1,000% Upside Potential
ACHL
InvestorPlaceMay 21, 2023

If you're a risk taker on the lookout for stocks with 1000% upside potential, you'd have to venture into speculative territory. It is difficult to find analyst ratings with such a high upside potential unless catalysts could propel the stock that high.

FAQ

  • What is the ticker symbol for Achilles Therapeutics?
  • Does Achilles Therapeutics pay dividends?
  • What sector is Achilles Therapeutics in?
  • What industry is Achilles Therapeutics in?
  • What country is Achilles Therapeutics based in?
  • When did Achilles Therapeutics go public?
  • Is Achilles Therapeutics in the S&P 500?
  • Is Achilles Therapeutics in the NASDAQ 100?
  • Is Achilles Therapeutics in the Dow Jones?
  • When was Achilles Therapeutics's last earnings report?
  • When does Achilles Therapeutics report earnings?
  • Should I buy Achilles Therapeutics stock now?

What is the ticker symbol for Achilles Therapeutics?

The ticker symbol for Achilles Therapeutics is NASDAQ:ACHL

Does Achilles Therapeutics pay dividends?

No, Achilles Therapeutics does not pay dividends

What sector is Achilles Therapeutics in?

Achilles Therapeutics is in the Healthcare sector

What industry is Achilles Therapeutics in?

Achilles Therapeutics is in the Biotechnology industry

What country is Achilles Therapeutics based in?

Achilles Therapeutics is headquartered in United Kingdom

When did Achilles Therapeutics go public?

Achilles Therapeutics's initial public offering (IPO) was on March 31, 2021

Is Achilles Therapeutics in the S&P 500?

No, Achilles Therapeutics is not included in the S&P 500 index

Is Achilles Therapeutics in the NASDAQ 100?

No, Achilles Therapeutics is not included in the NASDAQ 100 index

Is Achilles Therapeutics in the Dow Jones?

No, Achilles Therapeutics is not included in the Dow Jones index

When was Achilles Therapeutics's last earnings report?

Achilles Therapeutics's most recent earnings report was on Nov 14, 2024

When does Achilles Therapeutics report earnings?

The next expected earnings date for Achilles Therapeutics is Apr 4, 2025

Should I buy Achilles Therapeutics stock now?

As of today, analysts generally recommend a 'Sell' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions